Eventide Asset Management’s Immunovant IMVT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,390,000
| Closed | -$21.6M | – | 148 |
|
|
2023
Q1 | $21.6M | Sell |
1,390,000
-2,303,720
| -62% | -$35.7M | 0.4% | 77 |
|
|
2022
Q4 | $65.6M | Sell |
3,693,720
-1,678,792
| -31% | -$29.8M | 1.29% | 26 |
|
|
2022
Q3 | $30M | Hold |
5,372,512
| – | – | 0.59% | 54 |
|
|
2022
Q2 | $21M | Hold |
5,372,512
| – | – | 0.45% | 67 |
|
|
2022
Q1 | $29.6M | Buy |
5,372,512
+422,512
| +9% | +$2.33M | 0.46% | 64 |
|
|
2021
Q4 | $42.2M | Hold |
4,950,000
| – | – | 0.54% | 65 |
|
|
2021
Q3 | $43M | Buy |
4,950,000
+1,579,006
| +47% | +$13.7M | 0.57% | 58 |
|
|
2021
Q2 | $35.6M | Buy |
3,370,994
+897,994
| +36% | +$9.49M | 0.48% | 64 |
|
|
2021
Q1 | $39.7M | Buy |
2,473,000
+1,541,000
| +165% | +$24.7M | 0.59% | 61 |
|
|
2020
Q4 | $43M | Hold |
932,000
| – | – | 0.66% | 56 |
|
|
2020
Q3 | $32.8M | Buy |
932,000
+306,050
| +49% | +$10.8M | 0.64% | 55 |
|
|
2020
Q2 | $15.2M | Buy |
+625,950
| New | +$15.2M | 0.33% | 78 |
|